Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

47.80 -0.23 (-0.48%)
Streaming Delayed Price Updated: 10:48 AM EST, Dec 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
July 04, 2006
Form 425
Source: SEC/Edgar
July 04, 2006
Form 8-K
Source: SEC/Edgar
June 29, 2006
Form 8-K
Source: SEC/Edgar
June 28, 2006
Form 8-K
Source: SEC/Edgar
June 27, 2006
Form 8-K
Source: SEC/Edgar
June 25, 2006
Form 8-A12G
Source: SEC/Edgar
June 08, 2006
Form S-4/A
Source: SEC/Edgar
May 31, 2006
Form 8-K
Source: SEC/Edgar
May 31, 2006
Form 8-K
Source: SEC/Edgar
May 23, 2006
Form SC 13G/A
Source: SEC/Edgar
May 22, 2006
Form 8-K
Source: SEC/Edgar
May 18, 2006
Form 8-K
Source: SEC/Edgar
May 17, 2006
Form 10QSB
Source: SEC/Edgar
May 14, 2006
Form 8-K
Source: SEC/Edgar
May 14, 2006
Form 8-K/A
Source: SEC/Edgar
May 09, 2006
Form 8-K
Source: SEC/Edgar
May 09, 2006
Form 8-K
Source: SEC/Edgar
May 07, 2006
Form S-8
Source: SEC/Edgar
May 04, 2006
Form 8-K
Source: SEC/Edgar
May 04, 2006
Form 8-K
Source: SEC/Edgar
April 20, 2006
Form S-4
Source: SEC/Edgar
April 12, 2006
Form 424B3
Source: SEC/Edgar
April 11, 2006
Form 424B3
Source: SEC/Edgar
April 11, 2006
Form SC 13D
Source: SEC/Edgar
April 10, 2006
Form 10KSB/A
Source: SEC/Edgar
April 04, 2006
Form S-4
Source: SEC/Edgar
April 04, 2006
Form SB-2
Source: SEC/Edgar
April 02, 2006
Form 8-K
Source: SEC/Edgar
April 02, 2006
Form DEF 14A
Source: SEC/Edgar
March 30, 2006
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.